Isarna Therapeutics Stock

isarna-therapeutics.comHealthcare / BioTech & PharmaFounded: 1900Funding to Date: $131.24MM

Isarna Therapeutics is a clinical stage biotech company developing ISTH0036, a next-generation antisense to block TGF-beta 2 production, a key molecule in the pathogenesis of retinal disease.

Register To Buy and Sell Shares

For more details on financing and valuation for Isarna Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Isarna Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Isarna Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Philippe Calais Ph.D
Chief Executive Officer
Karl-Hermann Schlingensiepen
Owner & Co-Founder

Frequently Asked Questions About Isarna Therapeutics’ Stock

Can you buy Isarna Therapeutics’ stock?
Isarna Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Isarna Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Isarna Therapeutics’ stock?
Yes, you can sell stock of a private company like Isarna Therapeutics. Forge can help you sell your Isarna Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Isarna Therapeutics’ stock price?
Isarna Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Isarna Therapeutics’ private market stock price with Forge Data.
What is Isarna Therapeutics’ stock ticker symbol?
Isarna Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.